Clinical Trial Results: A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication [Phase 3]

View source ↗

Summary

Phase 3 study evaluating lebekizumab in uncontrolled asthma patients on inhaled corticosteroids and a second controller, with completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2026-07-17